Teva partners with Israeli institutes for early-stage drug research
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz, to discuss the company’s 2019 outlooks in Tel Aviv, Israel February…